Atlas Trials

Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in Schizophrenia

Clinical trial NCT07759895 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07759895
Sponsor
Amit Lotan
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Schizoaffecitve DisorderSchizophrenia and Schizoaffective DisorderSchizophrenia and Predominant Negative Symptoms
Start date
2026-09-01
Primary completion
2028-12-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.